首页> 美国政府科技报告 >Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic.

【24h】

Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic.

机译：针对乳腺癌中的雄激素受体：恩杂鲁胺作为一种新型乳腺癌治疗药物。

获取原文

页面导航

著录项
相似文献
相关主题

著录项

作者
Elias, A.;
展开▼
作者单位

展开▼
年度 2016
页码 1-13
总页数 13
原文格式 PDF
正文语种 eng
中图分类
关键词
Breast cancer;

机译：乳腺癌;

相似文献

外文文献
中文文献
专利

1. Estrogen receptor beta increases sensitivity to enzalutamide in androgen receptor-positive triple-negative breast cancer [J] . Anestis Aristomenis, Sarantis Panagiotis, Theocharis Stamatios, Journal of Cancer Research and Clinical Oncology . 2019,第5期

机译：雌激素受体β增加对雄激素受体阳性三重阴性乳腺癌对苯甲乙酰胺的敏感性
2. Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts [J] . Florence Coussy, Marion Lavigne, Leanne de Koning, Theranostics . 2020,第4期

机译：对烯醇酰胺抗性腔内雄激素受体三重阴性乳腺癌患者衍生异种移植物的响应MTOR和PI3K抑制剂
3. Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR plus ) triple negative breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：患者报告的结果（优点）在一年期间的佐剂依齐甲酰胺治疗早期雌激素受体阳性（AR Plus）三重阴性乳腺癌
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. Receptor tyrosine kinase-like orphan receptor-1 (ROR1) expression in breast cancer stem cells can be targeted for anti-cancer-stem-cell therapy [D] . Liu, Grace. 2015

机译：乳腺癌干细胞中受体酪氨酸激酶样孤儿受体1（ROR1）的表达可用于抗癌干细胞治疗
6. Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts [O] . Florence Coussy, Marion Lavigne, Leanne de Koning, 2020

机译：耐enzalutamide的管腔雄激素受体三阴性乳腺癌患者源性异种移植物中对mTOR和PI3K抑制剂的反应
7. Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic [O] . Anthony Elias 2014

机译：靶向乳腺癌中的雄激素受体：麒麟酰胺作为一种新型乳腺癌治疗
8. Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic. [R] . 2015

机译：针对乳腺癌中的雄激素受体：恩杂鲁胺作为一种新型乳腺癌治疗药物。

Targeting Androgen Receptor in Breast Cancer: Enzalutamide as a Novel Breast Cancer Therapeutic.

著录项

相似文献

相关主题

期刊订阅